Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.56
-0.07 (-1.93%)
At close: Aug 21, 2025, 11:26 AM

Altimmune Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
20K 20K 20K 52K 409K 410K 426K 279K -81K -79K -68K 3.32M 3.48M 3.6M 4.41M 3.45M 6.23M 6.81M
Cost of Revenue
67K 98K 205K 2.1M 20.45M 20.39M 19.92M 18.14M 20.02M 36.01M 36.48M 57.42M 66.36M 63.64M 74.52M 68.48M 56.32M 59.64M
Gross Profit
-10K 20K -87K -1.95M -19.98M -33.23M -32.75M -31.12M -33.35M -36.09M -36.55M -54.1M -62.89M -60.04M -70.11M -65.04M -50.09M -52.83M
Operating Income
-94.37M -98.19M -103.17M -111.93M -109.7M -100.96M -95.93M -85.4M -87.61M -90M -87.74M -88.63M -97.08M -101.55M -96.91M -83.68M -68.8M -62.35M
Interest Income
6.16M 7.21M 8.07M 8.47M 8.44M 8.1M 7.35M 7.04M 6.21M 4.7M 3.05M 1.58M 538K 243K 264K 132.36K 164.49K 212.94K
Pretax Income
-88.43M -90.92M -95.06M -103.52M -101.35M -92.77M -88.45M -78.47M -81.51M -85.55M -84.91M -87.14M -96.94M -101.66M -97.09M -83.93M -68.68M -62.19M
Net Income
-87.75M -90.24M -95.06M -103.52M -101.35M -92.77M -86.76M -75.35M -78.19M -82.24M -83.21M -86.87M -96.87M -101.59M -97.09M -83.82M -68.08M -60.02M
Selling & General & Admin
21.74M 21.65M 20.97M 20.21M 19.75M 18.92M 18.14M 17.61M 17.59M 17.24M 17.13M 17.11M 16.77M 16.02M 15.41M 15.75M 15.81M 14.7M
Research & Development
72.65M 76.57M 82.23M 79.35M 77.94M 70.04M 65.8M 68.07M 69.94M 72.68M 70.54M 71.54M 80.49M 77.77M 74.54M 63.31M 51.14M 54.46M
Other Expenses
n/a n/a -107K -2M -2M -2M -1.87M -198K -148K -123K -32K 104.36K -231.83K -230.74K -373.87K -317.97K -2.55K -34.53K
Operating Expenses
94.39M 98.21M 103.08M 97.56M 95.69M 86.96M 82.05M 85.68M 87.53M 89.92M 87.67M 88.65M 97.26M 93.79M 89.95M 79.05M 66.96M 69.16M
Interest Expense
272K 9K 9K 10K 33K 34K 35K 33K 68K 131K 191K 191K 160K 117K 67K 68.95K 38.23K 19.54K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
94.39M 98.21M 103.19M 111.98M 110.11M 101.37M 96.36M 85.68M 87.53M 89.92M 87.67M 88.65M 97.26M 93.79M 89.95M 79.05M 66.96M 69.16M
Income Tax Expense
-681K -681K n/a n/a n/a n/a -1.68M -3.12M -3.31M -3.22M -1.61M -176K -232.33K -274.01K -226.47K -336.82K -565.5K -2.19M
Shares Outstanding (Basic)
81.48M 75.55M 71.26M 71.08M 70.92M 70.8M 58.25M 53.63M 50.69M 50.13M 50.03M 48.99M 47.5M 43.97M 41.71M 41.37M 41.36M 38.91M
Shares Outstanding (Diluted)
81.48M 75.55M 71.26M 71.08M 70.92M 70.8M 58.44M 53.63M 50.69M 50.13M 50.03M 49.29M 47.5M 43.97M 41.71M 41.37M 41.36M 38.91M
EPS (Basic)
-1.18 -1.26 -1.34 -1.55 -1.62 -1.59 -1.62 -1.48 -1.57 -1.67 -1.74 -1.91 -2.24 -2.42 -2.36 -2.06 -1.79 -2.13
EPS (Diluted)
-1.18 -1.26 -1.34 -1.55 -1.62 -1.59 -1.62 -1.48 -1.57 -1.67 -1.74 -1.91 -2.24 -2.42 -2.36 -2.06 -1.79 -2.13
EBITDA
-89.1M -90.75M -94.81M -101.42M -99.14M -90.62M -86.76M -80.11M -83.23M -87.16M -85.98M -86.44M -96.17M -100.91M -96.44M -83.53M -68.34M -61.88M
EBIT
-88.16M -90.91M -95.05M -103.51M -101.31M -92.73M -88.41M -78.62M -81.62M -85.61M -84.9M -87.01M -96.84M -101.6M -97.08M -83.86M -68.64M -62.17M
Depreciation & Amortization
129K 160K 238K 2.1M 2.17M 2.23M 1.77M -354K -612K -680K -205K 362.38K 610.02K 632.11K 587.41K 335.15K 301.4K 299K